Loading: 100%
NATURAL ALTERNATIVES INTERNATIONAL INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Consumer Packaged Goods, Consumer DefensiveConsumer Packaged Goods, Consumer Defensiveno data available
Ticker NAIIno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1779111315
datesClosing price (adj.)
13.10.201710.75
11.10.201710.70
04.10.201710.57
27.09.201710.70
20.09.201710.45
13.09.201710.95
06.09.201710.80
30.08.201711.15
23.08.201710.40
16.08.201710.60
09.08.20179.35
02.08.201710.00
26.07.201710.05
19.07.201710.10
12.07.201710.10
05.07.20179.75
27.06.201710.15
20.06.201710.00
13.06.201710.25
06.06.201710.50
30.05.201710.90
23.05.201710.30
16.05.20179.80
09.05.20179.70
02.05.20179.65
25.04.20179.55
18.04.20179.30
11.04.20179.10
04.04.20179.45
28.03.20178.70
21.03.20178.70
14.03.20178.45
07.03.20178.75
28.02.20179.10
21.02.20179.25
14.02.201710.95
07.02.201711.45
31.01.201711.40
24.01.201711.45
17.01.201711.75
10.01.201712.00
03.01.201711.45
27.12.201611.50
19.12.201611.70
12.12.201611.25
05.12.201612.00
28.11.201613.40
21.11.201612.65
14.11.201611.90
07.11.201612.20
31.10.201612.60
24.10.201613.75
17.10.201613.70
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
10.75n/a
Market Capitalisation
in million USD
74n/a
Enterprise Value
in million USD
54n/a
Common Shares Outstanding
as per Jun 30, 2016
6,868,628n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
6,523,555n/a
Average Diluted Shares Outstanding
TTM
6,640,728n/a
Index Membership
n/a
Business Summary
Natural Alternatives International provides contract manufacturing services to companies that market & distribute vitamins, minerals, herbs and other nutritional supplements, as well as other health care products to customers within and outside the U.S.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 20n/a
Receivables 13n/a
Total Current Assets 56n/a
PP&E 15n/a
Total Assets 74n/a
Accounts Payable 13n/a
Current Debt 0n/a
Total Current Liabilities 19n/a
Long-Term Debt 0n/a
Total Liabilities 20n/a
Total Equity 54n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital -1n/a
Operating Cash Flow 9n/a
Net Change in PP&E and Intangibles -7n/a
Investing Cash Flow -7n/a
Dividends Paid 0n/a
Financing Cash Flow -1n/a
Total Change in Cash 1n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 8.24n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 1.31n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.73n/a
Other Ratios
Current Ratio 291.0%n/a
Liabilities to Equity Ratio 38.1%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 8% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
56
73
63
74
80
114
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-45
-57
-51
-61
-65
-89
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
11
15
12
13
14
25
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-8
-9
-10
-10
-10
-13
Selling, General & Administrative
-8
-9
-10
-10
-10
-13
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
2
6
2
3
4
12
Non-Operating Income (Loss)
0
0
0
0
0
-1
Interest Expense, net
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
2
6
2
3
4
12
Abnormal Gains (Losses)
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
2
6
2
3
4
12
Income Tax (Expense) Benefit, net
3
-2
-1
-1
-1
-4
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
5
4
2
2
4
8
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
5
4
2
2
4
8
Minority Interest
0
0
0
0
0
0
Net Income
5
4
2
2
4
8
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
5
4
2
2
4
8
Remarks
restated on Sep 21, 2012 n/a
calculated values,
restated on Sep 19, 2013 n/a
calculated values,
restated on Sep 25, 2014 n/a
calculated values,
restated on Sep 18, 2015 n/a
calculated values,
restated on Sep 19, 2016 n/a
calculated values,
restated on Sep 19, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
15
14
17
20
19
20
Cash & Cash Equivalents
15
14
17
20
19
20
Short Term Investments
0
0
0
0
0
0
Accounts & Notes Receivable
3
9
7
7
10
13
Accounts Receivable, Net
3
9
7
7
10
13
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
6
8
10
13
13
21
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
3
3
2
2
3
2
Prepaid Expenses
1
2
1
1
2
2
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
2
1
1
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
Total Current Assets
28
35
35
41
44
56
Property, Plant & Equipment, Net
11
11
9
9
8
15
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
2
2
2
3
3
3
Intangible Assets
0
0
0
0
0
0
Goodwill
0
0
0
0
0
0
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
1
1
2
2
2
2
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
1
1
1
1
Total Noncurrent Assets
13
13
11
11
10
18
Total Assets
41
47
47
52
54
74
Liabilities and owners' equity
Payables & Accruals
5 4947000
7 6836000
6 5942000
10 9600000
9 9093000
19 19205000
Accounts Payable
2 2232000
4 3918000
4 3539000
6 6418000
5 4647000
13 12821000
Accrued Taxes
0 472000
0 328000
0 466000
0 379000
0 489000
1 1340000
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
2 2243000
3 2590000
2 1937000
3 2803000
4 3957000
5 5044000
Short Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
5 4947000
7 6836000
6 5942000
10 9600000
9 9093000
19 19205000
Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
1 719000
0 493000
0 359000
0 220000
1 863000
1 1244000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 134000
0 183000
0 439000
1 758000
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
1 719000
0 493000
0 225000
0 37000
0 424000
0 486000
Total Noncurrent Liabilities
1 719000
0 493000
0 359000
0 220000
1 863000
1 1244000
Total Liabilities
6 5666000
7 7329000
6 6301000
10 9820000
10 9956000
20 20449000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
19 19429000
20 19602000
20 19735000
20 19939000
20 20333000
21 21215000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
-2 -1525000
-2 -1930000
-3 -2633000
-3 -2693000
-5 -4714000
-5 -5362000
Retained Earnings
18 17939000
22 22097000
24 23667000
26 25661000
29 29007000
39 38553000
Other Equity
0 -365000
0 99000
0 -430000
0 -469000
-1 -766000
-1 -680000
Equity Before Minority Interest
35 35478000
40 39868000
40 40339000
42 42438000
44 43860000
54 53726000
Minority Interest
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
35 35478000
40 39868000
40 40339000
42 42438000
44 43860000
54 53726000
Total Liabilities & Equity
41 41144000
47 47197000
47 46640000
52 52258000
54 53816000
74 74175000
Remarks restated on Sep 21, 2012 n/a restated on Sep 19, 2013 n/a restated on Sep 25, 2014 n/a restated on Sep 18, 2015 n/a restated on Sep 19, 2016 n/a restated on Sep 19, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
5
4
2
2
3
10
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
3
3
3
3
2
2
Non-Cash Items
-3
1
0
1
1
-1
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
3
-6
-1
0
-4
-1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
9
2
4
5
3
9
Change in Fixed Assets & Intangibles
-2
-2
-2
-2
-2
-7
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-2
-2
-2
-2
-2
-7
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
-1
0
-2
-1
Increase in Capital Stock
0
0
0
0
0
0
Decrease in Capital Stock
0
0
-1
0
-2
-1
Other Financing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
-1
0
-1
0
-2
-1
Net Cash Before Disc. Operations and FX
7
-1
2
3
-1
1
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
7
-1
2
3
-1
1
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
7
-1
2
3
-1
1
Remarks
restated on Sep 21, 2012 n/a
calculated values,
restated on Sep 19, 2013 n/a
calculated values,
restated on Sep 25, 2014 n/a
calculated values,
restated on Sep 18, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Sep 19, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo